Smruthi Organics Limited (BOM:540686)
153.25
-15.55 (-9.21%)
At close: Nov 16, 2026
Smruthi Organics Revenue
Smruthi Organics had revenue of 307.31M INR in the quarter ending September 30, 2026, a decrease of -2.73%. This brings the company's total for the last twelve months to 1.12B, down -6.98% year-over-year. In the fiscal year ending March 31, 2026, Smruthi Organics had annual revenue of 1.02B, down -19.08%. That makes Smruthi Organics the 36,621st largest company in the world by revenue and 3,159th in India.
Revenue (ttm)
1.12B
Revenue Growth
-6.98%
P/S Ratio
1.57
Revenue / Employee
4.27M
Employees
261
Market Cap
1.75B
Revenue by Segment
Fiscal year ended Mar 31, 2026 See the full Smruthi Organics breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.02B | -240.41M | -19.08% |
| Mar 31, 2025 | 1.26B | -16.35M | -1.28% |
| Mar 31, 2024 | 1.28B | -133.98M | -9.50% |
| Mar 31, 2023 | 1.41B | 76.70M | 5.75% |
| Mar 31, 2022 | 1.33B | 68.71M | 5.43% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Aarey Drugs & Pharmaceuticals | 4.20B |
| Influx Healthtech | 1.65B |
| Resonance Specialties | 1.14B |
| Panchsheel Organics | 1.10B |
| Kimia Biosciences | 1.04B |
| Tyche Industries | 503.78M |
| Accretion Nutraveda | 489.95M |
| Himalaya Nutravedics India | 430.68M |